Fintel on MSN11h
Citigroup Upgrades ResMed (RMD)
Fintel reports that on March 5, 2025, Citigroup upgraded their outlook for ResMed (NYSE:RMD) from Neutral to Buy. Analyst ...
Citi Remains a Buy on GE Healthcare Technologies Inc (GEHC)
In a report released today, Joanne Wuensch from Citi reiterated a Buy rating on GE Healthcare Technologies Inc (GEHC – Research Report). The ...
Morningstar15d
Sabra Health Care REIT, Inc. to Attend Citi’s 2025 Global Property CEO Conference and the 2025 NIC Spring Conference
Sabra Health Care REIT, Inc. (Nasdaq ... the company’s Executive Vice President of Finance, will attend Citi’s 2025 Global Property CEO Conference on March 3-5, 2025 at The Diplomat Beach ...
Citigroup upgrades Indian stocks to ’Overweight’ despite market crash, sets Nifty’s year-end target as THIS
Citigroup upgraded Indian stocks to overweight, citing meaningful upside amid less demanding valuations, predicting the NSE ...
Citigroup upgrades Indian stocks from neutral to overweight, sours on Asean
Citigroup Inc. upgraded Indian stocks to overweight from neutral, while turning underweight on equities in Southeast Asia.
Yahoo Finance15d
Sabra Health Care REIT, Inc. to Attend Citi’s 2025 Global Property CEO Conference and the 2025 NIC Spring Conference
February 18, 2025--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (Nasdaq ... the company’s Executive Vice President of Finance, will attend Citi’s 2025 Global Property CEO Conference on March 3-5, ...